DrugPatentWatch Database Preview
Email this page to a colleague» See Plans and Pricing
« Back to Dashboard
Acetamide is an investigational drug.
There have been 14 clinical trials for Acetamide. The most recent clinical trial was a Phase 2 trial, which was initiated on August 15th 2018.
The most common disease conditions in clinical trials are Cognition Disorders, Acute Pain, and Lymphoma. The leading clinical trial sponsors are California Pacific Medical Center Research Institute, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), and The University of Hong Kong.
There are three US patents protecting this investigational drug and thirty-four international patents.
Recent Clinical Trials for Acetamide
|Senicapoc and Dehydrated Stomatocytosis||Quest Diagnostics||Phase 3|
|Senicapoc and Dehydrated Stomatocytosis||Boston Children’s Hospital||Phase 3|
|Modafinil's Effects on Cognition in Remitted MDD||Ontario Ministry of Health and Long Term Care||Phase 3|
Top disease conditions for Acetamide
Top clinical trial sponsors for Acetamide
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Acetamide||Start Trial||Method for processing silver halide color photographic material for prints||Fuji Photo Film Co., Ltd. (Kanagawa, JP)||Start Trial|
|Acetamide||Start Trial||1-aryl-1-hydroxy-1-substitute d-3-(4-substituted-1-piperazinyl)-2-propanones and their use in treatment of neurogenic bladder disorders||Marion Laboratories, Inc. (Kansas City, MO)||Start Trial|
|Acetamide||Start Trial||7-substituted bicyclic pyrazolidinones||Eli Lilly and Company (Indianapolis, IN)||Start Trial|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|Acetamide||European Patent Office||0231861||2006-01-27||Start Trial|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|